SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-06-004781
Filing Date
2006-03-13
Accepted
2006-03-13 06:08:05
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a18351e10vk.htm 10-K 610213
2 EXHIBIT 10.12 a18351exv10w12.htm EX-10.12 91662
3 EXHIBIT 23.1 a18351exv23w1.htm EX-23.1 2502
4 EXHIBIT 31.1 a18351exv31w1.htm EX-31.1 8221
5 EXHIBIT 31.2 a18351exv31w2.htm EX-31.2 8216
6 EXHIBIT 32.1 a18351exv32w1.htm EX-32.1 4505
  Complete submission text file 0000950134-06-004781.txt   726725
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 06680792
SIC: 2836 Biological Products, (No Diagnostic Substances)